Search for: "Generic Pharmaceutical Association" Results 21 - 40 of 3,017
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2024, 3:35 pm by Mark Walsh
(Katie Barlow) In the bar section, Kristen Waggoner, the president and general counsel of Alliance Defending Freedom, the organization representing the anti-abortion doctors and medical associations that challenged FDA’s actions on mifepristone. [read post]
26 Mar 2024, 12:12 pm by Amy Howe
Solicitor General Elizabeth Prelogar argues on behalf of the FDA. [read post]
25 Mar 2024, 12:39 pm by Amy Howe
The drug at the center of the case is known by the generic name mifepristone. [read post]
18 Mar 2024, 6:00 am by Sherica Celine
Importantly, HIPAA does not cover many entities and types of data involved in the healthcare system, including health apps, fitness trackers, university student health clinics, or most pharmaceutical companies. [read post]
18 Mar 2024, 6:00 am by Sherica Celine
Antonious Sadek is a pharmacist and associate in DLA Piper’s Product Liability, Mass Tort, and Product Stewardship group. [read post]
7 Mar 2024, 7:58 am by Overhauser Law Offices, LLC
Patent Office issued the following 312 patents to persons and businesses in Indiana in January 2024: Patent Number                           Patent Title US 11886208 B2 Electronic user interface for electronic mixing of water for residential faucets US 11884752 B2 Inhibited non-pregelatinized granular starches US 11883335 B2 Medical products storage device including access… [read post]
5 Mar 2024, 2:25 pm by Harbir Deol
  Services: Generally, payments for the provision of services must be settled in the domestic foreign exchange market within 5 business days from the date the service was rendered. [read post]
5 Mar 2024, 11:47 am by Kurt R. Karst
Also, the IRA would subject Farxiga to the negotiated maximum fair price for the entirety of 2026 if no generic version entered the market before August 1, 2024, even if a generic drug later enters the market before or during 2026. [read post]
28 Feb 2024, 2:00 pm
  “General causation” refers to whether a substance is capable of causing a particular injury or condition in the general population. [read post]
27 Feb 2024, 12:59 pm by Laura Ray
The National Association of Attorneys General (NAAG) recently sent a letter to Congressional leaders urging them “to engage in meaningful debate and reform of the current practices of pharmacy benefit managers (PBMs) and to take decisive action to reform the way PBMs conduct business and bring more transparency to their work. [read post]
26 Feb 2024, 10:00 pm by Sherica Celine
Recent efforts by the FTC in this space include requesting public comment on how powerful “middlemen” in the generic drug market may contribute to shortages of these drugs. [read post]
23 Feb 2024, 3:11 pm by Courtney Finerty-Stelzner
The Anti-Fraud Coalition whistleblower advocacy group reports that Principal Deputy Assistant Attorney General Brian M. [read post]
22 Feb 2024, 10:30 pm by Lisa Kriegler
     The case is Safeline Pharmaceuticals (Pty) Ltd v Director General National Department of Health and Others (48004/2021) [2024] ZAGPPHC 138 (13 February 2024). [read post]
19 Feb 2024, 12:55 pm by Dennis Crouch
  Teva and Apotex, filed Abbreviated New Drug Applications (ANDAs) with the FDA seeking to market generic versions of the $100m+ drug. [read post]
18 Feb 2024, 6:00 am by Yosi Yahoudai
He utilized the tools available to him, which consisted primarily of pharmaceuticals and talk therapy, neither of which were effective in combating the issues he was facing. [read post]
12 Feb 2024, 9:05 pm by Melissa Bredbenner
Today, many consumers confront high drug prices set by major pharmaceutical companies. [read post]